Results
|
681.
|
|
|
682.
|
|
|
683.
|
|
|
684.
|
|
|
685.
|
|
|
686.
|
|
|
687.
|
|
|
688.
|
|
|
689.
|
Mature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1. [electronic resource] by
- Heinrich, Tim
- Rengstl, Benjamin
- Muik, Alexander
- Petkova, Mina
- Schmid, Frederike
- Wistinghausen, Robin
- Warner, Kathrin
- Crispatzu, Giuliano
- Hansmann, Martin-Leo
- Herling, Marco
- von Laer, Dorothee
- Newrzela, Sebastian
Producer: 20140207
In:
Molecular therapy : the journal of the American Society of Gene Therapy vol. 21
Availability: No items available.
|
|
690.
|
|
|
691.
|
|
|
692.
|
|
|
693.
|
|
|
694.
|
|
|
695.
|
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. [electronic resource] by
- Harvey, Richard C
- Mullighan, Charles G
- Chen, I-Ming
- Wharton, Walker
- Mikhail, Fady M
- Carroll, Andrew J
- Kang, Huining
- Liu, Wei
- Dobbin, Kevin K
- Smith, Malcolm A
- Carroll, William L
- Devidas, Meenakshi
- Bowman, W Paul
- Camitta, Bruce M
- Reaman, Gregory H
- Hunger, Stephen P
- Downing, James R
- Willman, Cheryl L
Producer: 20100802
In:
Blood vol. 115
Availability: No items available.
|
|
696.
|
Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice. [electronic resource] by
- Lin, Tsung H
- Hegen, Martin
- Quadros, Elizabeth
- Nickerson-Nutter, Cheryl L
- Appell, Kenneth C
- Cole, Andrew G
- Shao, Yuefei
- Tam, Steve
- Ohlmeyer, Michael
- Wang, Bojing
- Goodwin, Debra G
- Kimble, Earl F
- Quintero, Jorge
- Gao, Min
- Symanowicz, Peter
- Wrocklage, Christopher
- Lussier, Jennifer
- Schelling, Scott H
- Hewet, Amha G
- Xuan, Dejun
- Krykbaev, Rustem
- Togias, Jenny
- Xu, Xin
- Harrison, Richard
- Mansour, Tarek
- Collins, Mary
- Clark, James D
- Webb, Maria L
- Seidl, Katherine J
Producer: 20100903
In:
Arthritis and rheumatism vol. 62
Availability: No items available.
|
|
697.
|
|
|
698.
|
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies. [electronic resource] by
- Hurwitz, Herbert
- Van Cutsem, Eric
- Bendell, Johanna
- Hidalgo, Manuel
- Li, Chung-Pin
- Salvo, Marcelo Garrido
- Macarulla, Teresa
- Sahai, Vaibhav
- Sama, Ashwin
- Greeno, Edward
- Yu, Kenneth H
- Verslype, Chris
- Dawkins, Fitzroy
- Walker, Chris
- Clark, Jason
- O'Reilly, Eileen M
Producer: 20190327
In:
Investigational new drugs vol. 36
Availability: No items available.
|
|
699.
|
|
|
700.
|
|